Document: Substances considered as not falling within the scope of Regulation (EC) No. 470/2009, with regard to residues of veterinary medicinal products in foodstuffs of animal origin-2025/7/25

Alternative Tools: Assessing Drug Manufacturing Facilities Identified in Pending Applications-2025/9/11

Page: Scientific publications-2025/10/15

图解海报 | 《国家药监局关于深化化妆品监管改革促进产业高质量发展的意见》系列解读（五）-2025/11/20

Document: European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with tracked changes-2025/12/15

Page: Quality of medicines questions and answers: Part 1-2026/1/28

Document: Opinion of the CVMP on the establishment of maximum residue limits: Fluralaner ( EMEA/V/MRL/004380/EXTN/0002)-2026/3/6

Document: Highlights - EMA - European Alliance of Associations for Rheumatology (EULAR) bilateral meeting - March 2026-2026/4/7

Assessing the Effects of Food on Drugs in INDs and NDAs – Clinical Pharmacology Considerations-2026/5/20

国家药监局综合司公开征求《关于优化细胞与基因治疗药品审评审批有关事项的公告（征求意见稿）》意见-2026/7/3